Gyre Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
GYRE chart
What traders are saying about $GYRE
Latest postsGyre Therapeutics, Inc. news
- Weekly Recap: Q3 revenue up 1%, loss and F351 inspections completed
TradingView ·
- Gyre Therapeutics, Inc. (GYRE) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- H.C. Wainwright Maintains Gyre Therapeutics(GYRE.US) With Buy Rating, Maintains Target Price $18
Moomoo ·
- Why Did Gyre Therapeutics, Inc. (NASDAQ:GYRE) See Total Cash Fall 15 Percent Year to Date?
Kalkine ·
- On $32.9M in Q3 revenue, Gyre Therapeutics (GYRE) swings from profit to loss.
Stock Titan ·
- Gyre Therapeutics earnings beat by $0.03, revenue topped estimates
Investing.com ·
- Gyre Therapeutics, Inc. (GYRE) Tops Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- Gyre Therapeutics FY26 Results: Sales guidance affirmed below estimate
scanx.trade ·
- Gyre Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Gyre Therapeutics Reports Third Quarter 2026 and Year-to-Date Financial Results with Business Updates
Yahoo Finance ·
- A lung-scarring drug brought Gyre $31.4 million in sales in one quarter.
Stock Titan ·
- Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance ·
Gyre Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $116.6M | $105.8M | $113.5M | $102.3M |
| Net income | $9.9M | $17.9M | -$85.5M | $4.3M |
| Diluted EPS | $0.02 | $0.05 | $-1.41 | $0.03 |
| Total assets (year end) | $219.8M | $125.4M | $116.5M | $84.8M |
| Cash and equivalents (year end) | $49.2M | $11.8M | $33.5M | $25.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gyre Therapeutics, Inc.
- Ticker
- GYRE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
Frequently asked questions
What exchange is Gyre Therapeutics, Inc. listed on?
Gyre Therapeutics, Inc. trades on the Nasdaq under the ticker symbol GYRE.
What industry is Gyre Therapeutics, Inc. in?
Gyre Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Gyre Therapeutics, Inc. headquartered?
Gyre Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Gyre Therapeutics, Inc.'s fiscal year end?
Gyre Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Gyre Therapeutics, Inc. report?
Gyre Therapeutics, Inc. reported $116.6M in revenue for calendar year 2025, according to its SEC filings.